Forrester Announces Full Conference Agenda For CX EMEA 2023
Forrester (Nasdaq: FORR) today announced the full conference agenda for its CX EMEA event being held in London and digitally on 10–11 May 2023. At a time when consumer brands are bracing for strong, macro-level headwinds, including inflation, talent shortages, and supply chain issues, a lack of shared vision across the business is a challenge. The time is now for customer-facing functions to establish a shared, collective understanding of the customer that creates value for their customers and drives sustainable growth for their business. Forrester finds that companies with high levels of alignment across functions including CX, marketing, and digital report 2.4x higher revenue growth and 2x higher growth in profitability than those with either some or no alignment.
Featuring immersive experiences, keynote presentations, case studies, and dedicated role-based breakout sessions, CX EMEA 2023 will offer the latest research insights, models, and frameworks to help CX, B2C marketing, and digital leaders align on priorities that drive long-term customer loyalty. Key topics include how to build a customer-obsessed organisation; how to leverage analytics and consumer insights to prove the ROI of CX; how to accelerate a CX practice in a digital environment; and how to navigate and protect consumer privacy.
Additionally, Forrester will celebrate its 2023 EMEA Customer-Obsessed Enterprise Award winner and share how the honouree exemplifies customer obsession by putting the customer at the centre of their leadership, strategy, and operations. Attendees can also network with industry peers, experience Forrester’s CX Certification course, and attend an invitation-only executive programme, the Executive Leadership Exchange, to put the Forrester thought leadership presented at the conference into practice.
Noteworthy sessions include:
- How To Lead A Customer-Obsessed Organisation. Learn the key habits of leaders who have transformed their organisations using the key tenets of customer obsession.
- Practice Responsible Design To Drive Sustainable Value. This session will discuss why responsible design has become a business imperative and how to mitigate unintended design consequences.
- How To Embrace Customer Lifetime Value. Fewer than half of global CX leaders can prove the ROI of their CX initiatives. This session will share how CX teams can demonstrate clear business value.
- The Digital Leaders Of Tomorrow. This session will help define the key attributes of leading digital executives.
- Get Ready For The Age Of Cookieless Marketing. Industry dynamics, strict privacy rules, and more protective consumer behaviours are challenging marketing. This session will offer advice to help B2C marketers succeed in this environment.
“Now more than ever, to thrive, businesses need to put customers at the heart of everything they do,” said Martin Gill, vice president and research director at Forrester and host of CX EMEA. “CX EMEA aims to show CX, marketing, and digital leaders how they can align around customer-focused priorities to craft a shared vision and turbocharge their growth engine to drive sustainable business outcomes such as better customer retention and higher revenue and profitability growth.”
- Register to attend Forrester’s CX EMEA event.
- View the full agenda and speakers for CX EMEA.
- Members of the press interested in attending, please contact email@example.com.
- Check out the Forrester Decisions services for Customer Experience, B2C Marketing Executives, and Digital Business & Strategy.
- Follow @Forrester and #ForrCX for updates.
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester’s proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the centre of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; 100 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230321005054/en/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Inca Arrives to USA, a Strong Outlook for Peru Tourism Recovery27.5.2023 18:00:00 EEST | Press release
The Inca emperor walks the streets of New York City while his retinue dances tirelessly along the way, garnering the attention of the passers-by who stopped to stare and take video of the captivating scene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230526005330/en/ Peruvian actors from Cusco promoting the Inti Raymi 2023 in New York City, as tourism in Peru is once more on the rise. (Photo: PROMPERÚ). This performance was displayed by 30 actors from Cusco, Peru, as a promotional strategy to get Peru back in the news and in front of potential visitors in a positive way. The upcoming Inti Raymi (Festival of the Sun), a thousand-year-old ritual worshiping the Sun God and asking him to make the days longer, was promoted in the Big Apple in order to put the most notable celebration of Cusco’s calendar in the international spotlight. Inti Raymi honors the Sun each June 24th and celebrates the winter solstice of the Southern H
10th Annual World Patient Safety, Science & Technology Summit Is Sold Out!27.5.2023 07:10:00 EEST | Press release
Registration for the 10th Annual Patient Safety, Science & Technology Summit is now closed. This in-person Summit marks the nonprofit’s 10th anniversary and will be held in Newport Beach, California, from June 1 to 2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230526005374/en/ Annual World Patient Safety, Science & Technology Summit (Photo: Business Wire) “We are very encouraged at the response we received for our first in-person Summit since Covid-19,” said Dr. Michael Ramsay, CEO, Patient Safety Movement Foundation. “Many organizations felt a significant setback caused by the Covid-19 pandemic, but I believe this Summit will be the perfect way to get back on course. We have an incredible program designed for our 10th anniversary, with renowned speakers from around the world, including President Bill Clinton, Dr. Don Berwick, Dr. Neelam Dhingra, Sir Liam Donaldson, Dr. Peter Pronovost, Dr. Jannicke Mellin-Olsen, Dr. Mic
Sims Limited Achieves Climate Leaders Asia-Pacific 2023 Recognition27.5.2023 05:49:00 EEST | Press release
Sims Limited (ASX: SGM), a global leader in sustainability and an enabler of the circular economy, has been named to the Financial Times 2023 Asia-Pacific Climate Leaders list for the second time. Sims Limited was one of 275 companies on the prestigious list, which highlights companies that have made genuine greenhouse gas emissions reductions relative to their revenues over a five-year period. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230526005346/en/ FT-Statista Climate Leaders 2023 logo (Graphic: Business Wire) For the second consecutive year, Financial Times and Statista examined publicly available disclosures of more than 2,000 companies in the Asia-Pacific region to compile the Climate Leaders Asia-Pacific list. The list is comprised of companies that achieved the greatest reduction in their core emissions intensity between 2016 and 2021 – that is, their Scope 1 and 2 greenhouse gas emissions in relation to revenu
Skyflow Radically Simplifies Data Residency26.5.2023 18:00:00 EEST | Press release
Today Skyflow, the data privacy vault company, announced new data residency capabilities including Asia-Pacific instances in Japan, Indonesia, India, and Bahrain, and an expansion of its footprint in EMEA and North America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230526005072/en/ (Graphic: Business Wire) With Skyflow, companies that store sensitive customer data can meet regulatory requirements for localized storage, provable and auditable data protection, and governance – simply by leveraging Skyflow’s global vault infrastructure. This enables global expansion to reach new customers in new markets, while minimizing complexity and cost. For example, SaaS ISVs can scale and sell their product in both EMEA and APAC without adding instances. Replicating Instances is Expensive and Slow Today, companies that want to expand internationally face a technically complex and expensive proposition: replicate all of your cloud inf
FORE Biotherapeutics to Present Promising New Data from Phase 1/2a Trial Evaluating Plixorafenib (FORE8394) in Patients With BRAF-Altered Advanced Solid and Central Nervous System Tumors at ASCO 202326.5.2023 16:00:00 EEST | Press release
FORE Biotherapeutics today announced new clinical data from the Phase 1/2a clinical trial for plixorafenib (FORE8394), a novel, investigational, small-molecule, next-generation, orally available selective inhibitor of BRAF alterations. The results demonstrate promising single-agent activity against BRAF-altered tumors, including primary central nervous system (CNS) tumors, and will be featured in presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 2-6, 2023, in Chicago, IL. “The updated data from our Phase 1/2a study further reinforces plixorafenib’s differentiated clinical profile,” said Stacie Shepherd, MD, PhD, and Chief Medical Officer of FORE. “Plixorafenib has demonstrated both promising antitumor activity with durable responses and favorable tolerability as a single agent in patients with advanced BRAF-altered tumors. Notably, plixorafenib has a striking safety profile as compared to the currently approved BRAF/MEK and investiga
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom